134 related articles for article (PubMed ID: 30636620)
1. Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68.
Revy A; Hallouard F; Joyeux-Klamber S; Skanjeti A; Rioufol C; Fraysse M
Curr Radiopharm; 2019; 12(3):229-237. PubMed ID: 30636620
[TBL] [Abstract][Full Text] [Related]
2. Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.
Uccelli L; Boschi A; Cittanti C; Martini P; Lodi L; Zappaterra E; Romani S; Zaccaria S; Cecconi D; Rambaldi I; Santi I; Panareo S; Giganti M; Bartolomei M
Curr Radiopharm; 2018; 11(2):130-137. PubMed ID: 29745348
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability and clinical implementation of 'ready-to-use'
Manoharan P; Lamarca A; Navalkissoor S; Calero J; Chan PS; Julyan P; Sierra M; Caplin M; Valle J
ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32188715
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
Gabriel M; Oberauer A; Dobrozemsky G; Decristoforo C; Putzer D; Kendler D; Uprimny C; Kovacs P; Bale R; Virgolini IJ
J Nucl Med; 2009 Sep; 50(9):1427-34. PubMed ID: 19690033
[TBL] [Abstract][Full Text] [Related]
5. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
[TBL] [Abstract][Full Text] [Related]
6. Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals.
Lewis MR; Reichert DE; Laforest R; Margenau WH; Shefer RE; Klinkowstein RE; Hughey BJ; Welch MJ
Nucl Med Biol; 2002 Aug; 29(6):701-6. PubMed ID: 12234596
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor.
Hope TA; Pampaloni MH; Nakakura E; VanBrocklin H; Slater J; Jivan S; Aparici CM; Yee J; Bergsland E
Abdom Imaging; 2015 Aug; 40(6):1432-40. PubMed ID: 25820755
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
9. A New Buffer for Gallium-68 Labeling Suitable for use in Nuclear Medicine; Triethanolamine (TEA).
Uğur A; Yaylali O; Yüksel D
Curr Radiopharm; 2023; 16(4):308-314. PubMed ID: 37218205
[TBL] [Abstract][Full Text] [Related]
10. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131.
De Decker M; Turner JH
Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of [99mTc]Tc-EDDA/HYNIC-TOC and [68Ga] Ga-DOTA-TOC in a syringe for intravenous administration.
Chaib S; Hallouard F; Chennell P; Darcissac C; Morelec I; Rioufol C; Sautou V; Fraysse M
Nucl Med Commun; 2020 Jan; 41(1):11-17. PubMed ID: 31764593
[TBL] [Abstract][Full Text] [Related]
12. Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE.
Velikyan I; Xu H; Nair M; Hall H
Nucl Med Biol; 2012 Jul; 39(5):628-39. PubMed ID: 22336375
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.
Gabriel M; Decristoforo C; Kendler D; Dobrozemsky G; Heute D; Uprimny C; Kovacs P; Von Guggenberg E; Bale R; Virgolini IJ
J Nucl Med; 2007 Apr; 48(4):508-18. PubMed ID: 17401086
[TBL] [Abstract][Full Text] [Related]
14. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
[TBL] [Abstract][Full Text] [Related]
15. Production of [
Kleynhans J; Rubow S; le Roux J; Marjanovic-Painter B; Zeevaart JR; Ebenhan T
J Labelled Comp Radiopharm; 2020 Nov; 63(13):553-563. PubMed ID: 32865290
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
[TBL] [Abstract][Full Text] [Related]
17. Preliminary PET/CT Imaging with Somatostatin Analogs [
Satpati D; Shinto A; Kamaleshwaran KK; Sarma HD; Dash A
Mol Imaging Biol; 2017 Dec; 19(6):878-884. PubMed ID: 28349291
[TBL] [Abstract][Full Text] [Related]
18. Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy.
Mukherjee A; Lohar S; Dash A; Sarma HD; Samuel G; Korde A
J Labelled Comp Radiopharm; 2015 Apr; 58(4):166-72. PubMed ID: 25765604
[TBL] [Abstract][Full Text] [Related]
19. Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals.
Eppard E; Wuttke M; Nicodemus PL; Rösch F
J Nucl Med; 2014 Jun; 55(6):1023-8. PubMed ID: 24752674
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry of [⁶⁸Ga]-labeled compounds.
Eberlein U; Lassmann M
Appl Radiat Isot; 2013 Jun; 76():70-4. PubMed ID: 22884623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
